<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Energy Res.</journal-id>
<journal-title>Frontiers in Energy Research</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Energy Res.</abbrev-journal-title>
<issn pub-type="epub">2296-598X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">860627</article-id>
<article-id pub-id-type="doi">10.3389/fenrg.2022.860627</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Energy Research</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Brazilin From <italic>Caesalpinia sappan</italic> L. Induced Apoptosis <italic>via</italic> mTOR and HO-1 Pathway in SW480 Human Colon Cancer Cells</article-title>
<alt-title alt-title-type="left-running-head">Hong et al.</alt-title>
<alt-title alt-title-type="right-running-head">Effects of Brazilin on Colon Cancer Cells</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hong</surname>
<given-names>On-Yu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cho</surname>
<given-names>Eugene</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/499250/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Jong-Suk</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Park</surname>
<given-names>Kwang-Hyun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1318989/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Biochemistry</institution>, <institution>Institute for Medical Science</institution>, <institution>Jeonbuk National University Medical School</institution>, <addr-line>Jeonju</addr-line>, <country>South Korea</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Emergency Medicine and BioMedical Science Graduate Program (BMSGP)</institution>, <institution>Chonnam National University</institution>, <addr-line>Gwangju</addr-line>, <country>South Korea</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Emergency Medical Rescue</institution>, <institution>Nambu University</institution>, <institution>Jeonbuk National University Medical School</institution>, <addr-line>Gwangju</addr-line>, <country>South Korea</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1235342/overview">Shuangxi Nie</ext-link>, Guangxi University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1288337/overview">Chang-Gu Hyun</ext-link>, Jeju National University, South Korea</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1671756/overview">Guang-Hua Xie</ext-link>, Yanbian University Hospital, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Kwang-Hyun Park, <email>khpark@jbnu.ac.kr</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Electrochemical Energy Conversion and Storage, a section of the journal Frontiers in Energy Research</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>04</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>10</volume>
<elocation-id>860627</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>01</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>02</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Hong, Cho, Kim and Park.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Hong, Cho, Kim and Park</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>The mTOR pathway is a crucial biological regulatory mechanism of cell growth, proliferation and cell death, and its inhibitors were new candidates of anticancer drugs through regulation of energy balance and metabolism. In the present study, whether brazilin and mTOR inhibitor (Torin1) exerts anti-cancer effects was evaluated and the mechanism of its regulation in colorectal cancer cells investigated. Brazilin showed dose- and time-dependent cytotoxicity of colorectal cancer cells (SW480 cells) through apoptosis pathways such as Bcl-2, Bax, as well as cleavage of caspase 3, caspase 9, and PARP1. In addition, brazilin reduced mammalian target of rapamycin (mTOR) phosphorylation in a dose- and time-dependent manner, and the mTOR inhibitor torin 1 blocked this phosphorylation. Brazilin also decreased heme oxygenase-1 (HO-1) expression in a dose- and time-dependent manner; however, hemin, a specific HO-1 substrate, markedly increased HO-1 expression. Torin 1 reduced hemin-induced HO-1 expression and increased colorectal cell death in a dose-dependent manner in the presence and absence of hemin. Moreover, nuclear factor erythroid 2&#x2013;related factor 2 (Nrf2) translocation into nucleus fraction was crucial role in brazilin-mediated apoptosis of colorectal cancer cells. These results showed that brazilin and torin1 might regulate the mTOR signaling pathway by decreasing mTOR phosphorylation. Furthermore, mTOR signaling was associated with brazilin-regulated HO-1 expression, which induced apoptosis in colorectal cancer cells. These results suggest that synthetic and/or natural mTOR inhibitors were useful candidate for treatment of colorectal cancer cells.</p>
</abstract>
<kwd-group>
<kwd>mammalian target of rapamycin (mTOR)</kwd>
<kwd>mTOR kinase inhibitor</kwd>
<kwd>mTOR phosphorylation</kwd>
<kwd>torin1</kwd>
<kwd>brazilin</kwd>
<kwd>heme oxygenase-1</kwd>
<kwd>colorectal cancer</kwd>
</kwd-group>
<contract-num rid="cn001">2019R1A2C1003454 2021R1A2C1091322 2020R1I1A1A01054100</contract-num>
<contract-sponsor id="cn001">National Research Foundation of Korea<named-content content-type="fundref-id">10.13039/501100003725</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The mammalian target of rapamycin (mTOR), the activated downstream molecule in the phosphatidylinositol 3-kinase (PI3K)/Akt pathway, plays a major role in regulation of translation initiation through interactions with two distinct proteins, raptor and rictor. mTORC1 is sensitive to rapamycin, while mTORC2 is insensitive to rapamycin (<xref ref-type="bibr" rid="B71">Sarbassov et al., 2005</xref>). Rapamycin interacts with the immunophilin FK506 binding protein (FKBP12) (<xref ref-type="bibr" rid="B69">Sabatini et al., 1994</xref>; <xref ref-type="bibr" rid="B35">Jacinto and Hall, 2003</xref>), and the rapamycin-FKBP12 complex binds to the FKBP12-rapamycin binding domain (FRB) of mTORC1 but not to the FRB of mTORC2 (<xref ref-type="bibr" rid="B36">Jacinto et al., 2004</xref>; <xref ref-type="bibr" rid="B70">Sarbassov et al., 2004</xref>). Heme oxygenase-1 (HO-1) is induced by rapamycin and wortmannin in human pulmonary artery endothelial cells and human pulmonary artery smooth muscle cells (<xref ref-type="bibr" rid="B81">Visner et al., 2003</xref>). Particularly, mTORC1 correlated to intracellular energy charges on storages/consumptions of ATP, oxygen and effects to DNA replications/damages and regulated metabolic pathway (<xref ref-type="bibr" rid="B73">Saxton and Sabatini, 2017</xref>). In addition, HO-1 is overexpressed in rapamycin-treated renal cancer cells (<xref ref-type="bibr" rid="B4">Banerjee et al., 2012</xref>). In Tsc2-deficient neurons, HO-1 expression is increased, but rapamycin inhibits this increase (<xref ref-type="bibr" rid="B16">Di Nardo et al., 2009</xref>). These findings suggest that the PI3K-mTOR signaling pathway plays a role in HO-1 expression.</p>
<p>HO-1 is a microsomal enzyme that catalyzes the degradation of heme to carbon monoxide (CO), free iron ion, and biliverdin (<xref ref-type="bibr" rid="B60">Maines, 1997</xref>). Subsequently, biliverdin is enzymatically converted to bilirubin by biliverdin reductase (<xref ref-type="bibr" rid="B21">Florczyk et al., 2008</xref>). HO-1 plays cytoprotective roles, demonstrating antioxidant (<xref ref-type="bibr" rid="B12">Clark et al., 2000</xref>), anti-inflammatory (<xref ref-type="bibr" rid="B86">Willis et al., 1996</xref>; <xref ref-type="bibr" rid="B43">Kapturczak et al., 2004</xref>), anti-proliferative (<xref ref-type="bibr" rid="B48">Lee et al., 1996</xref>; <xref ref-type="bibr" rid="B63">Peyton et al., 2002</xref>; <xref ref-type="bibr" rid="B15">Deng et al., 2004</xref>), and anti-apoptotic properties (<xref ref-type="bibr" rid="B6">Brouard et al., 2000</xref>; <xref ref-type="bibr" rid="B10">Choi et al., 2004</xref>). However, the anti-apoptotic properties of HO-1 facilitate tumor progression. HO-1 is highly expressed in various human tumor tissues compared with normal tissue, such as prostate cancer (<xref ref-type="bibr" rid="B59">Maines and Abrahamsson, 1996</xref>), lung cancer (<xref ref-type="bibr" rid="B14">Degese et al., 2012</xref>), oral squamous cell carcinoma (<xref ref-type="bibr" rid="B22">Gandini et al., 2012</xref>), and colon cancers (<xref ref-type="bibr" rid="B42">Kang et al., 2012</xref>; <xref ref-type="bibr" rid="B87">Yin et al., 2014</xref>; <xref ref-type="bibr" rid="B56">Liu et al., 2021</xref>). High HO-1 expression in non-small cell lung cancer patients is associated with poor prognosis (<xref ref-type="bibr" rid="B80">Tsai et al., 2012</xref>; <xref ref-type="bibr" rid="B84">Wang et al., 2020</xref>). Conversely, HO-1 is associated with favorable prognosis in colorectal cancer (<xref ref-type="bibr" rid="B5">Becker et al., 2007</xref>). Increased HO-1 expression inhibits apoptosis in colon cancer cell line CaCo2 (<xref ref-type="bibr" rid="B7">Busserolles et al., 2006</xref>). However, increased HO-1 expression induces apoptosis in HCT116 cells (<xref ref-type="bibr" rid="B1">Andr&#xe9;s et al., 2014</xref>). Therefore, the role of HO-1 remains controversial.</p>
<p>Plants could be a rich source of novel bioactive compounds (<xref ref-type="bibr" rid="B74">Si et al., 2008</xref>; <xref ref-type="bibr" rid="B31">Hu et al., 2016</xref>; <xref ref-type="bibr" rid="B85">Wang et al., 2021</xref>), which are relatively unexplored (<xref ref-type="bibr" rid="B76">Si et al., 2013a</xref>; <xref ref-type="bibr" rid="B32">Huayu Liu et al., 2021a</xref>). The search for components and compositions isolated from plants is a permanent challenge, which still leads to new discoveries (<xref ref-type="bibr" rid="B77">Si et al., 2013b</xref>; <xref ref-type="bibr" rid="B33">Huayu Liu et al., 2021b</xref>; <xref ref-type="bibr" rid="B79">Ting Xu et al., 2021</xref>). The major component of <italic>Caesalpinia sappan L</italic>., brazilin (7, 11b-dihydrobenz[b]indeno[1,2-d]pyran-3,6a,9,10 (6H)-tetrol), is a natural red pigment used for morphological observation (<xref ref-type="bibr" rid="B65">Puchtler and Sweat, 1964</xref>; <xref ref-type="bibr" rid="B64">Puchtler et al., 1986</xref>). Brazilin exhibits various biological activities, such as anti-cancer (<xref ref-type="bibr" rid="B49">Lee et al., 2013</xref>; <xref ref-type="bibr" rid="B88">Zhang et al., 2018</xref>), anti-inflammation (<xref ref-type="bibr" rid="B27">Hikino et al., 1977</xref>; <xref ref-type="bibr" rid="B3">Bae et al., 2005</xref>; <xref ref-type="bibr" rid="B72">Sasaki et al., 2007</xref>), cell protection from BrCCl3-induced hepatic disorder (<xref ref-type="bibr" rid="B62">Moon et al., 1992</xref>), induction of immunological tolerance (<xref ref-type="bibr" rid="B11">Choi and Moon, 1997</xref>; <xref ref-type="bibr" rid="B61">Mok et al., 1998</xref>), anti-platelet activity (<xref ref-type="bibr" rid="B34">Hwang et al., 1998</xref>), inhibition of protein kinase C and insulin receptor kinase (<xref ref-type="bibr" rid="B44">Kim et al., 1998</xref>), and induction of vasorelaxation (<xref ref-type="bibr" rid="B28">Hu et al., 2003</xref>). Brazilin upregulates HO-1 through phosphoinositide 3-kinase (PI3K), protein kinase B (PKB/Akt) and extracellular signal-regulated kinase (ERK) signaling pathways in auditory cells (<xref ref-type="bibr" rid="B9">Choi and Kim, 2008</xref>).</p>
<p>The effects of brazilin have been studied in other cells but not in colorectal cancer. Therefore, it is currently not known how brazilin regulates its target genes in colorectal cancer. In this present study, the anti-cancer effects of brazilin were investigated and its target gene clarified to understand the significance of brazilin in colorectal cancer.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Cell Culture and Reagents</title>
<p>Human colorectal cancer cell line SW480 was cultured in Dulbecco&#x2019;s modified Eagle&#x2019;s medium supplemented with 10% heat-inactivated fetal bovine serum, 100&#xa0;U/mL penicillin, and 100&#xa0;&#x3bc;g/ml streptomycin (Gibco, NY, United States) at 37&#xb0;C in a humidified atmosphere of 5% CO<sub>2</sub>. Brazilin was purchased from MP Biomedicals (Santa Ana, CA, United States). Hemin was purchased from Sigma-Aldrich (St. Louis, MO, United States). Torin1 was purchased from Tocris Bioscience (Avonmouth, Bristol, United Kingdom). The reagents were dissolved in dimethyl sulfoxide (DMSO), and aliquots were stored at &#x2212;80&#xb0;C. Stock solutions were diluted in culture medium before use to appropriate concentration.</p>
</sec>
<sec id="s2-2">
<title>Cell Viability Assay</title>
<p>Cells were seeded in 96 well plates at a numbers of 5 &#xd7; 10<sup>4</sup> cells per well. After 18&#xa0;h incubation, cells were incubated with various dose of brazilin, an inducer (hemin) of HO-1, and mTOR inhibitor (Torin1). After incubation for 48&#xa0;h or 72&#xa0;h, 20&#xa0;&#x3bc;L of the stock solution (final concentration 0.5&#xa0;mg/ml) of 3-(4,5-dimetylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma-Aldrich, MO, United States) was added to individual well, and further incubated for 30&#xa0;min in CO<sub>2</sub> incubator. After removal of the supernatant, 0.1&#xa0;ml of DMSO were added to each well. The formazan in each well were solubilized for 20&#xa0;min at room temperature, and the absorbance were measured at an 570&#xa0;nm using a microplate reader (SPECTRA MAX PLUS, Molecular Devices, CA, United States).</p>
</sec>
<sec id="s2-3">
<title>Western Blot Analysis</title>
<p>Cells were plated in 60-mm dishes at a density of 2.4 &#xd7; 10<sup>6</sup> cells. After overnight incubation, cells were treated with different concentrations of brazilin and mTOR inhibitor or hemin. After incubation for 48&#xa0;h or 72&#xa0;h, cells were scraped and lysed. Proteins (30&#xa0;&#x3bc;g) were separated on SDS-PAGE and transferred to PVDF membranes (GE Healthcare, United Kingdom). The blots were incubated overnight at 4&#xb0;C with primary HO-1 (SPA-896) (Stressgen, MI, United States), Bax (&#x23;2772), cleaved caspase-3 (&#x23;9664), cleaved caspase-9 (&#x23;9505), PARP (&#x23;9542), mTOR (&#x23;2972), phospho-mTOR (Ser2448) (&#x23;2971) (Cell Signaling Technology, MA, United States), Bcl-2 (SC-7382), Nrf2 (SC-722), PCNA (SC-7907), <italic>&#x3b2;</italic>-actin (SC-47778) (Santa Cruz Biotechnology, TX, United States) antibodies. The blots were washed with TBS-T buffer and incubated with secondary horseradish peroxidase conjugated goat anti-rabbit and anti-mouse IgG antibodies (Santa Cruz Biotechnology). The reaction was detected using a chemiluminescence system (Millipore, Bedford, MA, United States). The intensities of positive bands were quantitated by densitometry analysis program (ImageQuant LAS 4000, NJ, United States) and expressed as a ratio of control group on the basis of <italic>&#x3b2;</italic>-actin level.</p>
</sec>
<sec id="s2-4">
<title>Flow Cytometry</title>
<p>Cellular apoptosis was assessed with annexin V and propidium iodide (PI) staining using commercial apoptosis assay kit (V13241, Molecular Probes, OR, United States) according to the manufacturer&#x2019;s instruction. Briefly, SW480 cells were inoculated in a 6 well plate at a number of 1.5 &#xd7; 10<sup>6</sup> cells and incubated with brazilin for 72&#xa0;h. The cells were detached by trypsinization, washed with DPBS, and then resuspended in buffer at a concentration of 1 &#xd7; 10<sup>6</sup> cells/mL. Next, 5&#xa0;&#x3bc;L of FITC-conjugated annexin V and 2&#xa0;&#x3bc;L of PI were added to resuspended cells, followed by incubation at room temperature for 15&#xa0;min. The cells were washed and resuspended in binding buffer. The cells were analyzed using flow cytometry on a FACS Calibur (BD Biosciences, CA, United States).</p>
</sec>
<sec id="s2-5">
<title>Evaluation of Apoptosis</title>
<p>Apoptosis was assessed using the commercial assay kit (A1000, Biocolor Ltd., Northern Ireland) according to the manufacturer&#x2019;s instruction. Briefly, SW480 cells were seeded in a 96-well plate at a number of 5 &#xd7; 10<sup>4</sup> cells per well and incubated with brazilin for 72&#xa0;h. After incubation for the indicated time period, the culture mediums were replaced with fresh mediums containing assay dye. The morphologies of cells were observed under an inverted microscope.</p>
</sec>
<sec id="s2-6">
<title>Quantitative Real-Time Polymerase Chain Reaction</title>
<p>Total RNA was extracted (Bioneer, Seoul, Korea) and variation in mRNA level of all genes were normalized to the housekeeping gene, GAPDH. Data were expressed the mean &#xb1; S.E.M of three independent experiments (<xref ref-type="bibr" rid="B37">Jang et al., 2020</xref>).</p>
</sec>
<sec id="s2-7">
<title>Electrophoretic Mobility Shift Assay</title>
<p>Nuclear extracts of the cell were prepared and electrophoretic mobility shift assay (EMSA) were performed as described in previous reports (<xref ref-type="bibr" rid="B26">Hellman and Fried, 2007</xref>; <xref ref-type="bibr" rid="B37">Jang et al., 2020</xref>). Specific binding were controlled by competitive reaction by treatment of excess of cold Nrf2 oligonucleotide (50 folds).</p>
</sec>
<sec id="s2-8">
<title>Statistical Analysis</title>
<p>All data are presented as mean &#xb1; standard deviation (S D). Statistical analysis was performed using Student&#x2019;s t-test. Significant differences between groups were noted at <italic>p</italic> &#x3c; 0.05.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Inhibitory Effects of Brazilin on Cell Viability in Colorectal Cancer Cells</title>
<p>To investigate the effects of brazilin on cell viability in SW480 cells, the MTT assay was performed. A significantly greater inhibition of cell viability was observed with increasing concentration and duration of brazilin treatment (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Subsequently, to determine whether the signaling pathway underlying the cytotoxic mechanism of brazilin on SW480 cells was associated with apoptosis, elevation/reduction of apoptotic marker genes was analyzed using Western blot. The Bax expression was significantly increased and Bcl-2 decreased in brazilin-treated cells in a dose dependent manner. Parallelly, the cleaved caspase-3 and -9 level and PARP expression were significantly increased by brazilin treatment in a dose dependent manner in SW480 cells. (<xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The effects of brazilin on cell viability in colorectal cancer SW480 cells. <bold>(A)</bold> SW480 cells were treated with different dosages of brazilin for 48&#xa0;h or 72&#xa0;h. Cell viabilities were measured by MTT assay. Data are shown as mean &#xb1; SD of three independent experiments. The <italic>p</italic>-values determined using Student&#x2019;s t-test were &#x2a;<italic>p</italic> &#x3c; 0.05 compared with controls. <bold>(B)</bold> SW480 cells were treated with different concentrations of brazilin for 72&#xa0;h. Whole cell lysates were prepared, and apoptosis was assessed using Western blot analysis with anti-Bax, anti-Bcl2, anti-cleaved caspase-3, anti-cleaved caspase-9, and anti-PARP/cleaved PARP antibodies. After treatment with brazilin for 72&#xa0;h, cells were analyzed using APOPercentage Apoptosis Assay kit <bold>(C)</bold> and flow cytometry with annexin V and PI staining <bold>(D)</bold>. The experiments were repeated for at least of three times.</p>
</caption>
<graphic xlink:href="fenrg-10-860627-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Brazilin Downregulates Cell Viability <italic>via</italic> Apoptosis</title>
<p>To further investigate cell death caused by brazilin in SW480 cells, apoptotic cells were assessed using microscopic- and fluorometric-apoptosis assay. Results for microscopic apoptosis assay are presented in <xref ref-type="fig" rid="F1">Figure 1C</xref>. The pink-colored deposits indicated the existence of apoptotic cells, which were observed in brazilin-treated cells. In addition, the identifiable cells were significantly decreased compared with the control in microscopic windows. The Annexin V-FITC and PI double-stained cells also showed a significant increase in apoptotic cells (<xref ref-type="fig" rid="F1">Figure 1D</xref>).</p>
</sec>
<sec id="s3-3">
<title>Brazilin Downregulates mTOR Phosphorylation by Reducing HO-1 Expression</title>
<p>To investigate whether brazilin regulates mTOR phosphorylation in SW480 cells, Western blot analysis was performed. Brazilin treatments were reduced mTOR phosphorylation in a dose- (<xref ref-type="fig" rid="F2">Figure 2A</xref>) and time- (100&#xa0;&#x3bc;M brazilin) (<xref ref-type="fig" rid="F2">Figure 2B</xref>) dependent manner. In contrast, brazilin didn&#x2019;t show any affects to total endogenous mTOR level in the cells (<xref ref-type="fig" rid="F2">Figures 2A,B</xref>). While torin1, selective and potent ATP-competitive inhibitor of mTOR inhibitor, decreased mTOR phosphorylation (<xref ref-type="fig" rid="F2">Figure 2C</xref>). Similarly, torin1 also no affects were shown in changes of mTOR expression level in SW480 cells.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Effects of brazilin on mTOR phosphorylation in colorectal cancer SW480 cells. SW480 cells were treated with different concentrations of brazilin for 48&#xa0;h <bold>(A)</bold> and for indicated times with 100&#xa0;&#x3bc;M brazilin <bold>(B)</bold>. <bold>(C)</bold> SW480 cells were treated with various concentrations of Torin1 for 48&#xa0;h. Whole cell lysates were prepared, and phospho-mTOR was detected using Western blot analysis with anti-phospho-mTOR. The experiments were repeated for at least of three times.</p>
</caption>
<graphic xlink:href="fenrg-10-860627-g002.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>mTOR, Regulation of HO-1 Expression and Cell Viabilities</title>
<p>In previous studies, the mTOR inhibitor rapamycin was shown to increase or decrease HO-1 expression (<xref ref-type="bibr" rid="B81">Visner et al., 2003</xref>; <xref ref-type="bibr" rid="B89">Zhou et al., 2005</xref>; <xref ref-type="bibr" rid="B16">Di Nardo et al., 2009</xref>). Therefore, Western blot analysis was performed to investigate whether mTOR inhibition decreased HO-1 expression. In addition, hemin-induced HO-1 expression was decreased <italic>via</italic> increased or decreased downregulation of mTOR phosphorylation mediated by increased concentration of mTOR inhibitor (<xref ref-type="fig" rid="F3">Figure 3A</xref>). Subsequently, the MTT assay was performed with the mTOR inhibitor Torin1 to clarify the effect of mTOR inhibition on cell viability. Cell viability was significantly decreased in Torin1-treated cells (<xref ref-type="fig" rid="F3">Figure 3B</xref>). The cell protective effects of brazilin on HO-1 were confirmed using hemin and Torin1. Pretreatment with hemin prevented brazilin-induced cell death (<xref ref-type="fig" rid="F3">Figure 3C</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Torin1 inhibition of HO-1 expression in colorectal cancer SW480 cells. <bold>(A)</bold>. After pretreatment with hemin for 2&#xa0;h, SW480 cells were treated with different concentrations of Torin1 for 48&#xa0;h. Whole cell lysates were prepared, and HO-1 was detected using Western blot analysis with anti-HO-1. <bold>(B)</bold>. SW480 cells were treated with Torin1 for 48&#xa0;h. <bold>(C)</bold> After pretreatment with hemin and Torin1 for 2&#xa0;h, cells were treated with brazilin for 48&#xa0;h. Cell viability was measured using the MTT assay. Results shown are mean &#xb1; SD of three independent experiments. The <italic>p</italic>-values determined using Student&#x2019;s t-test were &#x2a;<italic>p</italic> &#x3c; 0.05 compared with cells treated only with torin1.<sup>&#x23;</sup>
<italic>p</italic> &#x3c; 0.05 vs. compared with cell treated with hemin only. The experiments were repeated for at least of three times.</p>
</caption>
<graphic xlink:href="fenrg-10-860627-g003.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>Effect of Brazilin on Hemin-Induced Nrf2 Activation in SW480 Cells</title>
<p>To further understanding the inhibitory roles of brazilin on HO-1-related regulation on transcription cascades, we determined whether brazilin inhibits Nrf2 activation in SW480 cells after stimulate with hemin as the HO-1 inducer (<xref ref-type="fig" rid="F4">Figure 4</xref>). Treatments of hemin were markedly increased translocation of Nrf2 into nucleus fraction from cytosol. In contrast, brazilin showed inhibitory effects on translocation of Nrf2 from cytosol to nuclear fraction in a dose-dependent manner. Whereas, hemin-induced decrease of Nrf2 level in cytosol were temporally recovered by 50&#xa0;&#x3bc;M brazilin but no significant changes shown in other high concentration of brazilin. These results indicate that the nuclear translocation of Nrf2 are a crucial key molecules on inhibition of hemin-induced HO-1 elevation and suggest that brazilin able to induces of apoptosis on colorectal cancer cells.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Blockage effects brazilin on hemin-mediated Nrf2 translocation into nuclear fraction. Cells were treated with indicated dosages of brazilin in the presence of hemin. After 4&#xa0;h incubation, fraction extracts of nuclear and cytoplasm were prepared. Nrf2 molecules were identified by Western blotting. PCNA and <italic>&#x3b2;</italic>-actin were used as loading controls for nuclear- and cytosol-specific marker protein, respectively. The experiments were repeated for at least of three times.</p>
</caption>
<graphic xlink:href="fenrg-10-860627-g004.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>Effect of Brazilin on Regulation of HO-1 Expression and Hemin-Induced Nrf2 Activation in SW480 Cells</title>
<p>To observe the effects of brazilin on hemin-induced HO-1 elevation in SW480 cells, we determined with quantitative real-time PCR (qPCR). The qPCR revealed that treatment of brazilin were markedly reduced mRNA levels of HO-1 in a dose-dependent manner (<xref ref-type="fig" rid="F5">Figure 5A</xref>). Furthermore, to understanding of inhibitory roles of brazilin on regulation of HO-1 transcription, we determined whether brazilin inhibits Nrf2 activation in SW480 cells on hemin-induced HO-1 expression model using EMSA (<xref ref-type="fig" rid="F5">Figure 5B</xref>). DNA binding activity of hemin-induced Nrf2 was markedly inhibited by treatment of brazilin in a dose-dependent manner. These results suggest that Nrf2 nuclear translocation is an pivotal roles on regulation of hemin-induced HO-1 expression and Nrf2 nuclear translocation.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Brazilin regulates <bold>(A)</bold> HO-1 expression and <bold>(B)</bold> Nrf2 DNA binding activity in SW480 cells. Cells were treated with indicated dosages of brazilin for 1&#xa0;h, and then further incubated with 50&#xa0;&#x3bc;M hemin for 24&#xa0;h. Relative ratio of HO-1 mRNA levels were calculated by qPCR with GAPDH as an internal control. Data are presented as Means &#xb1; SD of three independent experiments. &#x2a; <italic>p</italic> &#x3c; 0.05 vs. control group. The experiments were repeated for at least of three times.</p>
</caption>
<graphic xlink:href="fenrg-10-860627-g005.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>Colorectal cancer is a major medical burden worldwide. Therefore, many diagnoses and treatment strategies developed and regulated by biomedical approaches have been implemented to solve this problem. Recently, plants extractives have been attracting increasing interests (<xref ref-type="bibr" rid="B75">Si et al., 2009</xref>; <xref ref-type="bibr" rid="B54">Liu et al., 2020a</xref>; <xref ref-type="bibr" rid="B67">Rui Xu et al., 2020</xref>; <xref ref-type="bibr" rid="B47">Liu et al., 2021c</xref>; <xref ref-type="bibr" rid="B18">Du et al., 2022</xref>), and phytotherapy is thought to be a promising approach to treat diseases (<xref ref-type="bibr" rid="B30">Hu et al., 2014</xref>; <xref ref-type="bibr" rid="B58">Lu et al., 2019</xref>; <xref ref-type="bibr" rid="B55">Liu et al., 2020b</xref>; <xref ref-type="bibr" rid="B46">Liu et al., 2021b</xref>). In the present study, the effects of mTOR-mediated signaling on brazilin-induced apoptosis of colorectal cancer cells based on HO-1 expression were investigated. Torin 1 is a potent and selective ATP-competitive inhibitor of mTOR kinase (<xref ref-type="bibr" rid="B78">Thoreen et al., 2009</xref>), the catalytic subunit of two functionally distinct complexes (mTORC1 and mTORC2) that promotes cell survival, proliferation, and growth.</p>
<p>Basically, mTOR has various physiological roles including changes in utilizable energy metabolites from dietary energy sources for homeostasis of lives. Whereas these pathways involved to energy storage in fasting condition and/or starvation stages (<xref ref-type="bibr" rid="B73">Saxton and Sabatini, 2017</xref>), and regulates downstream pathway of nutrients absorption and utilization, such as sugar and amino acids (<xref ref-type="bibr" rid="B41">Kalender et al., 2010</xref>). Therefore, mTOR and its regulation mechanism were important pathway as switch of energy storage and utilization in animals.</p>
<p>Unlike rapamycin, classical mTOR inhibitors, torin 1 was effectively blocked the phosphorylation of mTORC1 and mTORC2 (<xref ref-type="bibr" rid="B53">Liu et al., 2010</xref>). Furthermore, Brazilin has been reported to induce apoptosis of various cancer cells (<xref ref-type="bibr" rid="B88">Zhang et al., 2018</xref>; <xref ref-type="bibr" rid="B49">Lee et al., 2013</xref>), and the present study results showed that brazilin significantly inhibited cell viability and induced apoptosis in SW480 cells. Many natural compounds including brazilin were previously shown to increase HO-1 expression in normal or/and various disease models (<xref ref-type="bibr" rid="B9">Choi and Kim, 2008</xref>; <xref ref-type="bibr" rid="B37">Jang et al., 2020</xref>; <xref ref-type="bibr" rid="B13">Consoli et al., 2021</xref>; <xref ref-type="bibr" rid="B29">Hu et al., 2009</xref>); however, effects of brazilin on colorectal cancer cells have not been reported to date. These previous reports have been led to the prediction of useful for cancer mTOR-mediated cancer therapy. In early generation, all rapamycin analogs (CCI-779) (Wyeth, LLC, NJ, United States), AP23573 (Ariad Pharmaceuticals, MA, United States), RAD001 (Novartis International AG, Basel, Switzerland) have been launched (<xref ref-type="bibr" rid="B25">Guertin and Sabatini, 2007</xref>; <xref ref-type="bibr" rid="B19">Easton and Houghton, 2006</xref>, <xref ref-type="bibr" rid="B20">Faivre et al., 2006</xref>, <xref ref-type="bibr" rid="B24">Granville et al., 2006</xref>). In late 2010, official clinical trial information site in US (<ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov">ClinicalTrials.gov</ext-link>, National Cancer Institute, MD, United States) were registered larger than 150 trials with novel mTOR inhibitors to investigation as anticancer therapies for FDA approve (<xref ref-type="bibr" rid="B82">Wander et al., 2011</xref>). Recently, mTOR resistance mutant-selective novel mTOR inhibitor (<xref ref-type="bibr" rid="B66">Rodrik-Outmezguine et al., 2016</xref>) and the torin family were suggested for cancer therapy (<xref ref-type="bibr" rid="B8">Chen and Zhou, 2020</xref>). Whereas, poor information were existed between novel mTOR inhibitor and HO-1 pathway on cancer therapy then mandating more clinical research.</p>
<p>Interestingly, brazilin was reported ameliorative functions on diabetic nephropathy inflammation (<xref ref-type="bibr" rid="B50">Li et al., 2017</xref>), antidepressant- and anxiolytic- like effects (<xref ref-type="bibr" rid="B83">Wang et al., 2019</xref>), <italic>Staphylococcus aureus</italic>-induced mastitis (<xref ref-type="bibr" rid="B23">Gao et al., 2015</xref>), and renal ischemia-reperfusion injury (<xref ref-type="bibr" rid="B38">Jia et al., 2016</xref>) in animal model. However, the animal models for examine the anti-cancer effects of brazilin were poor therefore these results suggest that required novel candidate for screening of drugs with analogues. Moreover, brazilin has not been used for the clinical treatment of disease, then more basic results and evidences of this natural/synthetic molecules (<xref ref-type="bibr" rid="B40">Jung and Kim, 2015</xref>; <xref ref-type="bibr" rid="B2">Arredondo et al., 2019</xref>) and analogues are urgently needed.</p>
<p>Induction of HO-1 inhibits apoptosis through the Akt pathway (<xref ref-type="bibr" rid="B7">Busserolles et al., 2006</xref>). Rapamycin and wortmannin induce HO-1 in HPAEC, HPASMC, and renal cancer cells (<xref ref-type="bibr" rid="B81">Visner et al., 2003</xref>; <xref ref-type="bibr" rid="B4">Banerjee et al., 2012</xref>). In contrast, in Tsc2-deficient neurons, HO-1 expression is increased, though rapamycin inhibits this increase (<xref ref-type="bibr" rid="B16">Di Nardo et al., 2009</xref>). These results indicate that the PI3K/Akt/mTOR signaling pathway is involved in HO-1 expression. Therefore, hypothetically, brazilin regulates the mTOR signaling pathway. In the present study, brazilin decreased mTOR phosphorylation, and an mTOR inhibitor decreased HO-1 expression (<xref ref-type="fig" rid="F3">Figure 3</xref>). Accordingly, the study results showed that mTOR signaling was associated with brazilin-regulated HO-1 expression.</p>
<p>Induction of HO-1 has been shown to promote or inhibit apoptosis in colon cancer cells (<xref ref-type="bibr" rid="B7">Busserolles et al., 2006</xref>; <xref ref-type="bibr" rid="B1">Andr&#xe9;s et al., 2014</xref>). However, unlike previous studies, HO-1 expression was decreased in brazilin-treated cells in the present study. Furthermore, an HO-1 inducer prevented the reduction of brazilin-mediated cell viability. These results indicate that reduction of HO-1 expression mediates brazilin-induced inhibition of cell viability and apoptosis.</p>
<p>Recently, new-drug discovery and combinative chemotherapy using (nano)carriers and natural compounds are being investigated as new approaches and opportunities for cancer and other disorders treatment (<xref ref-type="bibr" rid="B51">Li et al., 2019</xref>; <xref ref-type="bibr" rid="B39">Jiayun Xu et al., 2020</xref>; <xref ref-type="bibr" rid="B57">Liu et al., 2022</xref>). In theory and practice fields, development of new biochemical/biomedical tools for personalized medicine in cancer treatment is unlimited (<xref ref-type="bibr" rid="B17">Du et al., 2019</xref>; <xref ref-type="bibr" rid="B52">Li et al., 2020</xref>; <xref ref-type="bibr" rid="B45">Liu et al., 2021a</xref>; <xref ref-type="bibr" rid="B68">Rui Xu et al., 2021</xref>). Therefore, personalized medicine important in effective therapy with low cost. By discovering the diverse potential of biomedicine, better healthcare tools can be provided based on the present study results.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>In the present study, brazilin downregulated HO-1 expression, which can lead to cell death. In addition, brazilin regulated HO-1 expression <italic>via</italic> reduction of mTOR phosphorylation, Nrf2 nuclear translocation in colorectal cancer cells. mTOR plays a crucial role in cancer biology and has emerged as a potential target for drug development. Therefore, brazilin is a potential therapeutic agent for treatment of colorectal cancer.</p>
</sec>
</body>
<back>
<sec id="s6">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s7">
<title>Ethics Statement</title>
<p>Ethical review and approval was not required for the study of human participants in accordance with the local legislation and institutional requirements. Written informed consent from the patients was not required to participate in this study in accordance with the national legislation and the institutional requirements.</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>Investigation, O-YH and EC; Supervision, K-HP and J-SK; Writing-original draft, K-HP; Writing-review and editing, K-HP.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (Nos 2019R1A2C1003454 and 2021R1A2C1091322) and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2020R1I1A1A01054100). This research was conducted with the support of BK21FOUR 21st century of Medical Science Creative Human Resource Development Center.</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andr&#xe9;s</surname>
<given-names>N. C.</given-names>
</name>
<name>
<surname>Fermento</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Gandini</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Romero</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Ferro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Donna</surname>
<given-names>L. G.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Heme Oxygenase-1 Has Antitumoral Effects in Colorectal Cancer: Involvement of P53</article-title>. <source>Exp. Mol. Pathol.</source> <volume>97</volume>, <fpage>321</fpage>&#x2013;<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexmp.2014.09.012</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arredondo</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Roa</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Gutman</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Huynh</surname>
<given-names>N. O.</given-names>
</name>
<name>
<surname>Van Vranken</surname>
<given-names>D. L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Total Synthesis of (&#xb1;)-Brazilin Using [4 &#x2b; 1] Palladium-Catalyzed Carbenylative Annulation</article-title>. <source>J. Org. Chem.</source> <volume>84</volume>, <fpage>14745</fpage>&#x2013;<lpage>14759</lpage>. <pub-id pub-id-type="doi">10.1021/acs.joc.9b02343</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bae</surname>
<given-names>I.-K.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>H.-Y.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>A.-R.</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>E.-K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. K.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Suppression of Lipopolysaccharide-Induced Expression of Inducible Nitric Oxide Synthase by Brazilin in RAW 264.7 Macrophage Cells</article-title>. <source>Eur. J. Pharmacol.</source> <volume>513</volume>, <fpage>237</fpage>&#x2013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2005.03.011</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banerjee</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wegiel</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Otterbein</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Mizumura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Gasser</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Heme Oxygenase-1 Promotes Survival of Renal Cancer Cells through Modulation of Apoptosis- and Autophagy-Regulating Molecules</article-title>. <source>J. Biol. Chem.</source> <volume>287</volume>, <fpage>32113</fpage>&#x2013;<lpage>32123</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m112.393140</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Becker</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Fukui</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Imai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sekikawa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yamagishi</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Colonic Expression of Heme Oxygenase-1 Is Associated with a Better Long-Term Survival in Patients with Colorectal Cancer</article-title>. <source>Scand. J. Gastroenterol.</source> <volume>42</volume>, <fpage>852</fpage>&#x2013;<lpage>858</lpage>. <pub-id pub-id-type="doi">10.1080/00365520701192383</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brouard</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Otterbein</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Anrather</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tobiasch</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bach</surname>
<given-names>F. H.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>A. M. K.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>Carbon Monoxide Generated by Heme Oxygenase 1 Suppresses Endothelial Cell Apoptosis</article-title>. <source>J. Exp. Med.</source> <volume>192</volume>, <fpage>1015</fpage>&#x2013;<lpage>1026</lpage>. <pub-id pub-id-type="doi">10.1084/jem.192.7.1015</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Busserolles</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Meg&#xed;as</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Terencio</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Alcaraz</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Heme Oxygenase-1 Inhibits Apoptosis in Caco-2 Cells <italic>via</italic> Activation of Akt Pathway</article-title>. <source>Int. J. Biochem. Cel Biol.</source> <volume>38</volume>, <fpage>1510</fpage>&#x2013;<lpage>1517</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2006.03.013</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Research Progress of mTOR Inhibitors</article-title>. <source>Eur. J. Med. Chem.</source> <volume>208</volume>, <fpage>112820</fpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2020.112820</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>B.-M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B.-R.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Upregulation of Heme Oxygenase-1 by Brazilin <italic>via</italic> the Phosphatidylinositol 3-kinase/Akt and ERK Pathways and its Protective Effect against Oxidative Injury</article-title>. <source>Eur. J. Pharmacol.</source> <volume>580</volume>, <fpage>12</fpage>&#x2013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2007.10.044</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>B.-M.</given-names>
</name>
<name>
<surname>Pae</surname>
<given-names>H.-O.</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>Y.-R.</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>G.-S.</given-names>
</name>
<name>
<surname>Jun</surname>
<given-names>C.-D.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B.-R.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Overexpression of Heme Oxygenase (HO)-1 Renders Jurkat T Cells Resistant to Fas-Mediated Apoptosis: Involvement of Iron Released by HO-1</article-title>. <source>Free Radic. Biol. Med.</source> <volume>36</volume>, <fpage>858</fpage>&#x2013;<lpage>871</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2004.01.004</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>S.-Y.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>C.-K.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Effects of Brazilin on the Altered Immune Functions in the Early Phase of Halothane Intoxication of C57BL/6 Mice</article-title>. <source>Planta Med.</source> <volume>63</volume>, <fpage>400</fpage>&#x2013;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1055/s-2006-957721</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clark</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Foresti</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Motterlini</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Dynamics of Haem Oxygenase-1 Expression and Bilirubin Production in Cellular protection against Oxidative Stress</article-title>. <source>Biochem. J.</source> <volume>348</volume>, <fpage>615</fpage>&#x2013;<lpage>619</lpage>. <pub-id pub-id-type="doi">10.1042/bj3480615</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Consoli</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Sorrenti</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Grosso</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vanella</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Heme Oxygenase-1 Signaling and Redox Homeostasis in Physiopathological Conditions</article-title>. <source>Biomolecules</source> <volume>11</volume>, <fpage>589</fpage>. <pub-id pub-id-type="doi">10.3390/biom11040589</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Degese</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Mendizabal</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Gandini</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Gutkind</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Molinolo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hewitt</surname>
<given-names>S. M.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Expression of Heme Oxygenase-1 in Non-small Cell Lung Cancer (NSCLC) and its Correlation with Clinical Data</article-title>. <source>Lung Cancer</source> <volume>77</volume>, <fpage>168</fpage>&#x2013;<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1016/j.lungcan.2012.02.016</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>Y.-M.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Witting</surname>
<given-names>P. K.</given-names>
</name>
<name>
<surname>Stocker</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Probucol Protects against Smooth Muscle Cell Proliferation by Upregulating Heme Oxygenase-1</article-title>. <source>Circulation</source> <volume>110</volume>, <fpage>1855</fpage>&#x2013;<lpage>1860</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.0000142610.10530.25</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Nardo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kramvis</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sadowski</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Meikle</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kwiatkowski</surname>
<given-names>D. J.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Tuberous Sclerosis Complex Activity Is Required to Control Neuronal Stress Responses in an mTOR-dependent Manner</article-title>. <source>J. Neurosci.</source> <volume>29</volume>, <fpage>5926</fpage>&#x2013;<lpage>5937</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0778-09.2009</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Si</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Cellulose Nanocrystals and Cellulose Nanofibrils Based Hydrogels for Biomedical Applications</article-title>. <source>Carbohydr. Polym.</source> <volume>209</volume>, <fpage>130</fpage>&#x2013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2019.01.020</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Parit</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Conductive PEDOT:PSS/cellulose Nanofibril Paper Electrodes for Flexible Supercapacitors with superior Areal Capacitance and Cycling Stability</article-title>. <source>Chem. Eng. J.</source> <volume>428</volume>, <fpage>131994</fpage>. <pub-id pub-id-type="doi">10.1016/j.cej.2021.131994</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Easton</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Houghton</surname>
<given-names>P. J.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>mTOR and Cancer Therapy</article-title>. <source>Oncogene</source> <volume>25</volume>, <fpage>6436</fpage>&#x2013;<lpage>6446</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1209886</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faivre</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kroemer</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Raymond</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Current Development of mTOR Inhibitors as Anticancer Agents</article-title>. <source>Nat. Rev. Drug Discov.</source> <volume>5</volume>, <fpage>671</fpage>&#x2013;<lpage>688</lpage>. <pub-id pub-id-type="doi">10.1038/nrd2062</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Florczyk</surname>
<given-names>U. M.</given-names>
</name>
<name>
<surname>Jozkowicz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dulak</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Biliverdin Reductase: New Features of an Old Enzyme and its Potential Therapeutic Significance</article-title>. <source>Pharmacol. Rep.</source> <volume>60</volume> (<issue>1</issue>), <fpage>38</fpage>&#x2013;<lpage>48</lpage>. </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gandini</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Fermento</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Salom&#xf3;n</surname>
<given-names>D. G.</given-names>
</name>
<name>
<surname>Blasco</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gutkind</surname>
<given-names>J. S.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Nuclear Localization of Heme Oxygenase-1 Is Associated with Tumor Progression of Head and Neck Squamous Cell Carcinomas</article-title>. <source>Exp. Mol. Pathol.</source> <volume>93</volume>, <fpage>237</fpage>&#x2013;<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexmp.2012.05.001</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gao</surname>
<given-names>X.-j.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.-c.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.-c.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.-g.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>N.-s.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>M.-y.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Brazilin Plays an Anti-inflammatory Role with Regulating Toll-like Receptor 2 and TLR 2 Downstream Pathways in Staphylococcus Aureus-Induced Mastitis in Mice</article-title>. <source>Int. Immunopharmacology</source> <volume>27</volume>, <fpage>130</fpage>&#x2013;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2015.04.043</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Granville</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Memmott</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Gills</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Dennis</surname>
<given-names>P. A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Handicapping the Race to Develop Inhibitors of the Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway</article-title>. <source>Clin. Cancer Res.</source> <volume>12</volume>, <fpage>679</fpage>&#x2013;<lpage>689</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.ccr-05-1654</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guertin</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Sabatini</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Defining the Role of mTOR in Cancer</article-title>. <source>Cancer Cell</source> <volume>12</volume>, <fpage>9</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2007.05.008</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hellman</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Fried</surname>
<given-names>M. G.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Electrophoretic Mobility Shift Assay (EMSA) for Detecting Protein-Nucleic Acid Interactions</article-title>. <source>Nat. Protoc.</source> <volume>2</volume>, <fpage>1849</fpage>&#x2013;<lpage>1861</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2007.249</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hikino</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Taguchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fujimura</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hiramatsu</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>1977</year>). <article-title>Antiinflammatory Principles Ofcaesalpinia Sappanwood and Ofhaematoxylon Campechianumwood1</article-title>. <source>Planta Med.</source> <volume>31</volume>, <fpage>214</fpage>&#x2013;<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1055/s-0028-1097516</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>J. J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Y. W.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Induction of Vasorelaxation through Activation of Nitric Oxide Synthase in Endothelial Cells by Brazilin</article-title>. <source>Eur. J. Pharmacol.</source> <volume>468</volume>, <fpage>37</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/s0014-2999(03)01639-x</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>C.-M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.-H.</given-names>
</name>
<name>
<surname>Cheah</surname>
<given-names>K.-P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.-S.</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>C.-S. K.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>W.-Y.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Heme Oxygenase-1 Mediates the Inhibitory Actions of Brazilin in RAW264.7 Macrophages Stimulated with Lipopolysaccharide</article-title>. <source>J. Ethnopharmacology</source> <volume>121</volume>, <fpage>79</fpage>&#x2013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2008.09.030</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Si</surname>
<given-names>C.-L.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Neuroprotective Effects of Macranthoin G from Eucommia Ulmoides against Hydrogen Peroxide-Induced Apoptosis in PC12 Cells <italic>via</italic> Inhibiting NF-&#x39a;b Activation</article-title>. <source>Chemico-Biological Interactions</source> <volume>224</volume>, <fpage>108</fpage>&#x2013;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2014.10.011</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Apigenin-7-O-<italic>&#x3b2;</italic>-d-glucuronide Inhibits LPS-Induced Inflammation through the Inactivation of AP-1 and MAPK Signaling Pathways in RAW 264.7 Macrophages and Protects Mice against Endotoxin Shock</article-title>. <source>Food Funct.</source> <volume>7</volume> (<issue>2</issue>), <fpage>1002</fpage>&#x2013;<lpage>1013</lpage>. <pub-id pub-id-type="doi">10.1039/C5FO01212K</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huayu Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2021a</year>). <article-title>Cellulose Based Composite Foams and Aerogels for Advanced Energy Storage Devices</article-title>. <source>Chem. Eng. J.</source> <volume>426</volume>, <fpage>130817</fpage>. <pub-id pub-id-type="doi">10.1016/j.cej.2021.130817</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huayu Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2021b</year>). <article-title>Lignin-based Electrodes for Energy Storage Application</article-title>. <source>Ind. Crops Prod.</source> <volume>165</volume>, <fpage>113425</fpage>. <pub-id pub-id-type="doi">10.1016/j.indcrop.2021.113425</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>G.-S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.-Y.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>T.-S.</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>S.-D.</given-names>
</name>
<name>
<surname>So</surname>
<given-names>D.-S.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>C.-K.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Effects of Brazilin on the Phospholipase A2 Activity and Changes of Intracellular Free Calcium Concentration in Rat Platelets</article-title>. <source>Arch. Pharm. Res.</source> <volume>21</volume>, <fpage>774</fpage>&#x2013;<lpage>778</lpage>. <pub-id pub-id-type="doi">10.1007/bf02976775</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacinto</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>M. N.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>TOR Signalling in Bugs, Brain and Brawn</article-title>. <source>Nat. Rev. Mol. Cel Biol</source> <volume>4</volume>, <fpage>117</fpage>&#x2013;<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1038/nrm1018</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jacinto</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Loewith</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>R&#xfc;egg</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Mammalian TOR Complex 2 Controls the Actin Cytoskeleton and Is Rapamycin Insensitive</article-title>. <source>Nat. Cel Biol</source> <volume>6</volume>, <fpage>1122</fpage>&#x2013;<lpage>1128</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1183</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>H.-Y.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>O.-Y.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>E.-Y.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>K.-H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.-S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Roles of JNK/Nrf2 Pathway on Hemin-Induced Heme Oxygenase-1 Activation in MCF-7 Human Breast Cancer Cells</article-title>. <source>Medicina</source> <volume>56</volume>, <fpage>268</fpage>. <pub-id pub-id-type="doi">10.3390/medicina56060268</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Brazilin Exerts Protective Effects against Renal Ischemia-Reperfusion Injury by Inhibiting the NF-&#x39a;b Signaling Pathway</article-title>. <source>Int. J. Mol. Med.</source> <volume>38</volume>, <fpage>210</fpage>&#x2013;<lpage>216</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.2016.2616</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiayun Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Biomass Fractionation and Lignin Fractionation towards Lignin Valorization</article-title>. <source>Chemsuschem</source> <volume>13</volume> (<issue>17</issue>), <fpage>4284</fpage>&#x2013;<lpage>4295</lpage>. <pub-id pub-id-type="doi">10.1002/cssc.202001491</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jung</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Total Synthesis of Brazilin</article-title>. <source>J. Org. Chem.</source> <volume>80</volume>, <fpage>2001</fpage>&#x2013;<lpage>2005</lpage>. <pub-id pub-id-type="doi">10.1021/jo502745j</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalender</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Selvaraj</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Gulati</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Br&#xfb;l&#xe9;</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Viollet</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-dependent Manner</article-title>. <source>Cel Metab.</source> <volume>11</volume>, <fpage>390</fpage>&#x2013;<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2010.03.014</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Maeng</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y. R.</given-names>
</name>
<name>
<surname>Piao</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K. C.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Involvement of Heme Oxygenase-1 in Korean colon Cancer</article-title>. <source>Tumor Biol.</source> <volume>33</volume>, <fpage>1031</fpage>&#x2013;<lpage>1038</lpage>. <pub-id pub-id-type="doi">10.1007/s13277-012-0336-0</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapturczak</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Wasserfall</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Brusko</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Campbell-Thompson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Atkinson</surname>
<given-names>M. A.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Heme Oxygenase-1 Modulates Early Inflammatory Responses</article-title>. <source>Am. J. Pathol.</source> <volume>165</volume>, <fpage>1045</fpage>&#x2013;<lpage>1053</lpage>. <pub-id pub-id-type="doi">10.1016/s0002-9440(10)63365-2</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S.-G.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.-M.</given-names>
</name>
<name>
<surname>Khil</surname>
<given-names>L.-Y.</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>S.-D.</given-names>
</name>
<name>
<surname>So</surname>
<given-names>D.-S.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>C.-H.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>Brazilin Inhibits Activities of Protein Kinase C and Insulin Receptor Serine Kinase in Rat Liver</article-title>. <source>Arch. Pharm. Res.</source> <volume>21</volume>, <fpage>140</fpage>&#x2013;<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1007/bf02974018</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2021a</year>). <article-title>Cellulose Nanomaterials for Oil Exploration Applications</article-title>. <source>Polym. Rev., </source>
<comment>in press.</comment> <fpage>1</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1080/15583724.2021.2007121</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2021b</year>). <article-title>Recent Advances in Cellulose and its Derivatives for Oilfield Applications</article-title>. <source>Carbohydr. Polym.</source> <volume>259</volume>, <fpage>117740</fpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2021.117740</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2021c</year>). <article-title>Lignin-containing Cellulose Nanomaterials: Preparation and Applications</article-title>. <source>Green. Chem.</source> <volume>23</volume>, <fpage>9723</fpage>&#x2013;<lpage>9746</lpage>. <pub-id pub-id-type="doi">10.1039/D1GC02841C</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wiegand</surname>
<given-names>G. W.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Overexpression of Heme Oxygenase-1 in Human Pulmonary Epithelial Cells Results in Cell Growth Arrest and Increased Resistance to Hyperoxia</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>93</volume>, <fpage>10393</fpage>&#x2013;<lpage>10398</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.93.19.10393</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>D.-Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M.-K.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>G.-S.</given-names>
</name>
<name>
<surname>Noh</surname>
<given-names>H.-J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M.-H.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Brazilin Inhibits Growth and Induces Apoptosis in Human Glioblastoma Cells</article-title>. <source>Molecules</source> <volume>18</volume>, <fpage>2449</fpage>&#x2013;<lpage>2457</lpage>. <pub-id pub-id-type="doi">10.3390/molecules18022449</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Z.-y.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>S.-b.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Brazilin Ameliorates Diabetic Nephropathy and Inflammation in Db/db Mice</article-title>. <source>Inflammation</source> <volume>40</volume>, <fpage>1365</fpage>&#x2013;<lpage>1374</lpage>. <pub-id pub-id-type="doi">10.1007/s10753-017-0579-4</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Production of 5-hydroxymethylfurfural and Levulinic Acid from Lignocellulosic Biomass and Catalytic Upgradation</article-title>. <source>Ind. Crops Prod.</source> <volume>130</volume>, <fpage>184</fpage>&#x2013;<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1016/j.indcrop.2018.12.082</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Nie</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Efficient Catalytic Production of Biomass-Derived Levulinic Acid over Phosphotungstic Acid in Deep Eutectic Solvent</article-title>. <source>Ind. Crops Prod.</source> <volume>145</volume>, <fpage>112154</fpage>. <pub-id pub-id-type="doi">10.1016/j.indcrop.2020.112154</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Thoreen</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Markhard</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Discovery of 1-(4-(4-Propionylpiperazin-1-Yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-Yl)benzo[h][1,6]naphthyridin-2(1h)-One as a Highly Potent, Selective Mammalian Target of Rapamycin (mTOR) Inhibitor for the Treatment of Cancer</article-title>. <source>J. Med. Chem.</source> <volume>53</volume>, <fpage>7146</fpage>&#x2013;<lpage>7155</lpage>. <pub-id pub-id-type="doi">10.1021/jm101144f</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020a</year>). <article-title>Highly Efficient and Sustainable Preparation of Carboxylic and Thermostable Cellulose Nanocrystals <italic>via</italic> FeCl3-Catalyzed Innocuous Citric Acid Hydrolysis</article-title>. <source>ACS Sust. Chem. Eng.</source> <volume>8</volume>, <fpage>16691</fpage>&#x2013;<lpage>16700</lpage>. <pub-id pub-id-type="doi">10.1021/acssuschemeng.0c06561</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2020b</year>). <article-title>Bacterial Cellulose-Based Composite Scaffolds for Biomedical Applications: a Review</article-title>. <source>ACS Sust. Chem. Eng.</source> <volume>8</volume>, <fpage>7536</fpage>&#x2013;<lpage>7562</lpage>. <pub-id pub-id-type="doi">10.1021/acssuschemeng.0c00125</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Si</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Sustainable Preparation of Cellulose Nanofibrils <italic>via</italic> Choline Chloride-Citric Acid Deep Eutectic Solvent Pretreatment Combined with High-Pressure Homogenization</article-title>. <source>Carbohydr. Polym.</source> <volume>267</volume>, <fpage>118220</fpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2021.118220</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Multifunctional Superelastic, Superhydrophilic, and Ultralight Nanocellulose-Based Composite Carbon Aerogels for Compressive Supercapacitor and Strain Sensor</article-title>. <source>Adv. Funct. Mater.</source> <volume>32</volume>, <fpage>2113082</fpage>. <pub-id pub-id-type="doi">10.1002/adfm.202113082</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Si</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Fabrication of Thermo- and pH-Sensitive Cellulose Nanofibrils-Reinforced Hydrogel with Biomass Nanoparticles</article-title>. <source>Carbohydr. Polym.</source> <volume>215</volume>, <fpage>289</fpage>&#x2013;<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2019.03.100</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maines</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Abrahamsson</surname>
<given-names>P.-A.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Expression of Heme Oxygenase-1 (HSP32) in Human Prostate: normal, Hyperplastic, and Tumor Tissue Distribution</article-title>. <source>Urology</source> <volume>47</volume>, <fpage>727</fpage>&#x2013;<lpage>733</lpage>. <pub-id pub-id-type="doi">10.1016/s0090-4295(96)00010-6</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maines</surname>
<given-names>M. D.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>The Heme Oxygenase System:A Regulator of Second Messenger Gases</article-title>. <source>Annu. Rev. Pharmacol. Toxicol.</source> <volume>37</volume>, <fpage>517</fpage>&#x2013;<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.pharmtox.37.1.517</pub-id> </citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mok</surname>
<given-names>M.-S.</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>S.-D.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>K.-M.</given-names>
</name>
<name>
<surname>So</surname>
<given-names>D.-S.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>C.-K.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Effects of Brazilin on Induction of Immunological Tolerance by Sheep Red Blood Cells in C57BL/6 Female Mice</article-title>. <source>Arch. Pharm. Res.</source> <volume>21</volume>, <fpage>769</fpage>&#x2013;<lpage>773</lpage>. <pub-id pub-id-type="doi">10.1007/bf02976774</pub-id> </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moon</surname>
<given-names>C.-K.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>K.-S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.-G.</given-names>
</name>
<name>
<surname>Won</surname>
<given-names>H.-S.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>J.-H.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>BRAZILIN PROTECTS CULTURED RAT HEPATOCYTES FROM BrCCI3-INDUCED TOXICITY</article-title>. <source>Drug Chem. Toxicol.</source> <volume>15</volume>, <fpage>81</fpage>&#x2013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.3109/01480549209035174</pub-id> </citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peyton</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Reyna</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Chapman</surname>
<given-names>G. B.</given-names>
</name>
<name>
<surname>Ensenat</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.-m.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>Heme Oxygenase-1-Derived Carbon Monoxide Is an Autocrine Inhibitor of Vascular Smooth Muscle Cell Growth</article-title>. <source>Blood</source> <volume>99</volume>, <fpage>4443</fpage>&#x2013;<lpage>4448</lpage>. <pub-id pub-id-type="doi">10.1182/blood.v99.12.4443</pub-id> </citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puchtler</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Meloan</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Waldrop</surname>
<given-names>F. S.</given-names>
</name>
</person-group> (<year>1986</year>). <article-title>Application of Current Chemical Concepts to Metal-Hematein And-Brazilein Stains</article-title>. <source>Histochemistry</source> <volume>85</volume>, <fpage>353</fpage>&#x2013;<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1007/bf00982665</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puchtler</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sweat</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>1964</year>). <article-title>On the Mechanism of Sequence Iron-Hematein Stains</article-title>. <source>Histochemie</source> <volume>4</volume>, <fpage>197</fpage>&#x2013;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1007/bf00290864</pub-id> </citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodrik-Outmezguine</surname>
<given-names>V. S.</given-names>
</name>
<name>
<surname>Okaniwa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Novotny</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>McWhirter</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Banaji</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Overcoming mTOR Resistance Mutations with a New-Generation mTOR Inhibitor</article-title>. <source>Nature</source> <volume>534</volume>, <fpage>272</fpage>&#x2013;<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1038/nature17963</pub-id> </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rui Xu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Falling Leaves Return to Their Roots: A Review on the Preparation of &#x3b3;&#x2010;Valerolactone from Lignocellulose and its Application in the Conversion of Lignocellulose</article-title>. <source>ChemSusChem</source> <volume>13</volume>, <fpage>6461</fpage>&#x2013;<lpage>6476</lpage>. <pub-id pub-id-type="doi">10.1002/cssc.202002008</pub-id> </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rui Xu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>An Efficient and Magnetic Adsorbent Prepared in a Dry Process with Enzymatic Hydrolysis Residues for Wastewater Treatment</article-title>. <source>J. Clean. Prod.</source> <volume>313</volume>, <fpage>127834</fpage>. <pub-id pub-id-type="doi">10.1016/j.jclepro.2021.127834</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabatini</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Erdjument-Bromage</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lui</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tempst</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>S. H.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>RAFT1: A Mammalian Protein that Binds to FKBP12 in a Rapamycin-dependent Fashion and Is Homologous to Yeast TORs</article-title>. <source>Cell</source> <volume>78</volume>, <fpage>35</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(94)90570-3</pub-id> </citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarbassov</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D.-H.</given-names>
</name>
<name>
<surname>Guertin</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Latek</surname>
<given-names>R. R.</given-names>
</name>
<name>
<surname>Erdjument-Bromage</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-independent Pathway that Regulates the Cytoskeleton</article-title>. <source>Curr. Biol.</source> <volume>14</volume>, <fpage>1296</fpage>&#x2013;<lpage>1302</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2004.06.054</pub-id> </citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sarbassov</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Sabatini</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Growing Roles for the mTOR Pathway</article-title>. <source>Curr. Opin. Cel Biol.</source> <volume>17</volume>, <fpage>596</fpage>&#x2013;<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceb.2005.09.009</pub-id> </citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sasaki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hosokawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nagai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nagumo</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>
<italic>In Vitro</italic> Study for Inhibition of NO Production about Constituents of Sappan Lignum</article-title>. <source>Biol. Pharm. Bull.</source> <volume>30</volume>, <fpage>193</fpage>&#x2013;<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.30.193</pub-id> </citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saxton</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Sabatini</surname>
<given-names>D. M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>mTOR Signaling in Growth, Metabolism, and Disease</article-title>. <source>Cell</source> <volume>168</volume>, <fpage>960</fpage>&#x2013;<lpage>976</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.02.004</pub-id> </citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Si</surname>
<given-names>C.-L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.-K.</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>Y.-S.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Structure Elucidation of Phenylethanoid Glycosides from <italic>Paulownia Tomentosa</italic> Steud. Var. <italic>Tomentosa</italic> wood</article-title>. <source>Holzforschung</source> <volume>62</volume>, <fpage>197</fpage>&#x2013;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1515/hf.2008.047</pub-id> </citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Si</surname>
<given-names>C.-L.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.-K.</given-names>
</name>
<name>
<surname>Bae</surname>
<given-names>Y.-S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.-M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Phenolic Compounds in the Leaves ofPopulus Ussuriensisand Their Antioxidant Activities</article-title>. <source>Planta Med.</source> <volume>75</volume>, <fpage>1165</fpage>&#x2013;<lpage>1167</lpage>. <pub-id pub-id-type="doi">10.1055/s-0029-1185476</pub-id> </citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Si</surname>
<given-names>C.-L.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>J.-Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.-C.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>H.-Y.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>X.-D.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>G.-J.</given-names>
</name>
<etal/>
</person-group> (<year>2013a</year>). <article-title>A New Lignan Glycoside and Phenolics from the branch wood of <italic>Pinus Banksiana</italic> Lambert</article-title>. <source>Holzforschung</source> <volume>67</volume>, <fpage>357</fpage>&#x2013;<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1515/hf-2012-0137</pub-id> </citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Si</surname>
<given-names>C.-L.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.-Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>G.-J.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>X.-D.</given-names>
</name>
<etal/>
</person-group> (<year>2013b</year>). <article-title>Antioxidant Properties and Neuroprotective Effects of Isocampneoside II on Hydrogen Peroxide-Induced Oxidative Injury in PC12 Cells</article-title>. <source>Food Chem. Toxicol.</source> <volume>59</volume>, <fpage>145</fpage>&#x2013;<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/j.fct.2013.05.051</pub-id> </citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thoreen</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>J. W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>An ATP-Competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-Resistant Functions of mTORC1</article-title>. <source>J. Biol. Chem.</source> <volume>284</volume>, <fpage>8023</fpage>&#x2013;<lpage>8032</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m900301200</pub-id> </citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ting Xu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Si</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Advanced Nanocellulose&#x2010;Based Composites for Flexible Functional Energy Storage Devices</article-title>. <source>Adv. Mater.</source> <volume>33</volume>, <fpage>2101368</fpage>. <pub-id pub-id-type="doi">10.1002/adma.202101368</pub-id> </citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname>
<given-names>J.-R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.-M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P.-L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.-H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>M.-C.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>S.-H.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>High Expression of Heme Oxygenase-1 Is Associated with Tumor Invasiveness and Poor Clinical Outcome in Non-small Cell Lung Cancer Patients</article-title>. <source>Cell Oncol.</source> <volume>35</volume>, <fpage>461</fpage>&#x2013;<lpage>471</lpage>. <pub-id pub-id-type="doi">10.1007/s13402-012-0105-5</pub-id> </citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Visner</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kazemfar</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Rapamycin Induces Heme Oxygenase-1 in Human Pulmonary Vascular Cells</article-title>. <source>Circulation</source> <volume>107</volume>, <fpage>911</fpage>&#x2013;<lpage>916</lpage>. <pub-id pub-id-type="doi">10.1161/01.cir.0000048191.75585.60</pub-id> </citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wander</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Hennessy</surname>
<given-names>B. T.</given-names>
</name>
<name>
<surname>Slingerland</surname>
<given-names>J. M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Next-generation mTOR Inhibitors in Clinical Oncology: How Pathway Complexity Informs Therapeutic Strategy</article-title>. <source>J. Clin. Invest.</source> <volume>121</volume>, <fpage>1231</fpage>&#x2013;<lpage>1241</lpage>. <pub-id pub-id-type="doi">10.1172/jci44145</pub-id> </citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xiu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Brazilin Treatment Produces Antidepressant- and Anxiolytic-like Effects in Mice</article-title>. <source>Biol. Pharm. Bull.</source> <volume>42</volume>, <fpage>1268</fpage>&#x2013;<lpage>1274</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.b18-00882</pub-id> </citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Highly Efficient Preparation of Functional and Thermostable Cellulose Nanocrystals <italic>via</italic> H2SO4 Intensified Acetic Acid Hydrolysis</article-title>. <source>Carbohydr. Polym.</source> <volume>239</volume>, <fpage>116233</fpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2020.116233</pub-id> </citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Sustainable Preparation of Bifunctional Cellulose Nanocrystals <italic>via</italic> Mixed H2SO4/formic Acid Hydrolysis</article-title>. <source>Carbohydr. Polym.</source> <volume>266</volume>, <fpage>118107</fpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2021.118107</pub-id> </citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willis</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Moore</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Frederick</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Willoughby</surname>
<given-names>D. A.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Heme Oxygenase: A Novel Target for the Modulation of Inflammatory Response</article-title>. <source>Nat. Med.</source> <volume>2</volume>, <fpage>87</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1038/nm0196-87</pub-id> </citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Upregulation of Heme Oxygenase-1 in Colorectal Cancer Patients with Increased Circulation Carbon Monoxide Levels, Potentially Affects Chemotherapeutic Sensitivity</article-title>. <source>BMC Cancer</source> <volume>14</volume>, <fpage>436</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2407-14-436</pub-id> </citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Brazilin Induces T24 Cell Death through C-Fos and GADD45<italic>&#x3b2;</italic> Independently Regulated Genes and Pathways</article-title>. <source>IUBMB Life</source> <volume>70</volume>, <fpage>1101</fpage>&#x2013;<lpage>1110</lpage>. <pub-id pub-id-type="doi">10.1002/iub.1921</pub-id> </citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Porvasnik</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Terada</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Heme Oxygenase-1 Mediates the Protective Effects of Rapamycin in Monocrotaline-Induced Pulmonary Hypertension</article-title>. <source>Lab. Invest.</source> <volume>86</volume>, <fpage>62</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1038/labinvest.3700361</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>